These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule. Food and Drug Administration, HHS. Fed Regist; 2007 Jun 25; 72(121):34751-958. PubMed ID: 17674484 [Abstract] [Full Text] [Related]
9. FDA perspectives on supplement use by patients on antithrombotic therapy. Kim MJ. Thromb Res; 2005 Jun 25; 117(1-2):197-200; discussion 201-7. PubMed ID: 16188297 [No Abstract] [Full Text] [Related]
11. Under the law, FDA must grant different standards for new dietary ingredients and food additives. Mister S, Hathcock J. Regul Toxicol Pharmacol; 2012 Apr 25; 62(3):456-8. PubMed ID: 22310217 [Abstract] [Full Text] [Related]
13. Maintaining a level playing field: the need for a uniform standard to evaluate health claims for foods and dietary supplements. Pappas CD. Food Drug Law J; 2002 Apr 25; 57(1):25-41. PubMed ID: 12118479 [No Abstract] [Full Text] [Related]
14. Food ingredient review at FDA: recent data and initiatives to improve the process. Rulis AM, Tarantino LM. Regul Toxicol Pharmacol; 1996 Dec 25; 24(3):224-31. PubMed ID: 8975749 [No Abstract] [Full Text] [Related]
16. Generally recognized as safe (GRAS): history and description. Burdock GA, Carabin IG. Toxicol Lett; 2004 Apr 15; 150(1):3-18. PubMed ID: 15068820 [Abstract] [Full Text] [Related]
17. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory? Silverglade BA. Food Drug Law J; 1996 Apr 15; 51(2):319-21. PubMed ID: 11822324 [No Abstract] [Full Text] [Related]